1. Home
  2. ALVO vs DBD Comparison

ALVO vs DBD Comparison

Compare ALVO & DBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALVO
  • DBD
  • Stock Information
  • Founded
  • ALVO 2013
  • DBD 1859
  • Country
  • ALVO Luxembourg
  • DBD United States
  • Employees
  • ALVO N/A
  • DBD N/A
  • Industry
  • ALVO Biotechnology: Pharmaceutical Preparations
  • DBD EDP Services
  • Sector
  • ALVO Health Care
  • DBD Technology
  • Exchange
  • ALVO Nasdaq
  • DBD Nasdaq
  • Market Cap
  • ALVO 2.5B
  • DBD 2.1B
  • IPO Year
  • ALVO N/A
  • DBD N/A
  • Fundamental
  • Price
  • ALVO $7.84
  • DBD $57.50
  • Analyst Decision
  • ALVO Strong Buy
  • DBD Strong Buy
  • Analyst Count
  • ALVO 2
  • DBD 3
  • Target Price
  • ALVO $14.00
  • DBD $73.33
  • AVG Volume (30 Days)
  • ALVO 352.1K
  • DBD 153.3K
  • Earning Date
  • ALVO 11-12-2025
  • DBD 11-05-2025
  • Dividend Yield
  • ALVO N/A
  • DBD N/A
  • EPS Growth
  • ALVO N/A
  • DBD N/A
  • EPS
  • ALVO 0.22
  • DBD N/A
  • Revenue
  • ALVO $562,478,000.00
  • DBD $3,672,300,000.00
  • Revenue This Year
  • ALVO $34.94
  • DBD $3.09
  • Revenue Next Year
  • ALVO $39.55
  • DBD $2.74
  • P/E Ratio
  • ALVO $36.05
  • DBD N/A
  • Revenue Growth
  • ALVO 82.19
  • DBD N/A
  • 52 Week Low
  • ALVO $7.35
  • DBD $34.88
  • 52 Week High
  • ALVO $13.70
  • DBD $63.46
  • Technical
  • Relative Strength Index (RSI)
  • ALVO 40.91
  • DBD 48.53
  • Support Level
  • ALVO $7.77
  • DBD $56.94
  • Resistance Level
  • ALVO $8.50
  • DBD $59.14
  • Average True Range (ATR)
  • ALVO 0.29
  • DBD 1.49
  • MACD
  • ALVO -0.08
  • DBD 0.14
  • Stochastic Oscillator
  • ALVO 5.49
  • DBD 55.50

About ALVO Alvotech

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.

About DBD Diebold Nixdorf Incorporated Common stock

Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are Banking, which offers integrated solutions for financial institutions, and Retail, which offers solutions, software, and services that improve the checkout process for retailers. A majority of its revenue is generated from the Banking segment. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA), followed by the Americas and the Asia-Pacific region.

Share on Social Networks: